Covista Unveils Purpose at Scale Healthcare Growth Strategy
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Adtalem Global Education ( (ATGE) ).
On February 24, 2026, Covista used its Investor Day to unveil “Purpose at Scale,” a three-year growth strategy starting in fiscal 2027 that builds on its earlier “Growth with Purpose” program to expand capacity, deepen employer workforce pipelines and accelerate AI-enabled curriculum innovation. The company also rebranded its NYSE listing to ticker CVSA that day, signaling its fully focused pivot from a diversified educator into a pure-play healthcare workforce platform.
The company reinforced its technology and market positioning by announcing a partnership with GE Healthcare’s HelloAI unit to advance AI fluency among healthcare students and professionals, and a founding role in the Alliance for Advancing Rural Healthcare with SAIC to bolster rural health systems and workforce pipelines. These moves aim to solidify Covista’s role in addressing the national clinician shortage, particularly in underserved regions, while differentiating it as a tech-forward educator embedded with major healthcare stakeholders.
Covista set long-term financial targets for fiscal 2027–2029, guiding to annual revenue growth rising from 6–8% to 8–11% and adjusted earnings per share growth accelerating from 9–13% to 12–16%, underpinned by disciplined capital allocation and selective M&A, partnerships and share repurchases. At the same time, it reaffirmed its fiscal 2026 outlook for revenue of $1.9 billion to $1.94 billion and adjusted EPS of $7.80 to $8.00, implying mid- to high-single-digit top-line expansion and double-digit profit growth as it invests in campuses and employer-linked programs.
Management framed these initiatives as evidence that the operational discipline built over the past three years—delivering record enrollment, margin expansion and execution—now supports a new phase of scaled growth and shareholder value creation. For investors and healthcare partners, the Investor Day positioned Covista as a critical, financially resilient player in solving the U.S. healthcare labor crisis, with explicit growth benchmarks and new strategic alliances underpinning its long-term narrative.
The most recent analyst rating on (ATGE) stock is a Hold with a $114.00 price target. To see the full list of analyst forecasts on Adtalem Global Education stock, see the ATGE Stock Forecast page.
Spark’s Take on ATGE Stock
According to Spark, TipRanks’ AI Analyst, ATGE is a Outperform.
The score is driven primarily by strong underlying financial performance (high margins and robust free cash flow) and supportive forward commentary (raised EPS guidance). These positives are tempered by weak technical momentum (below key moving averages with negative MACD) and execution risks highlighted around segment softness, timing-related volatility, and lending/regulatory uncertainty, while valuation appears reasonable at ~15.4x earnings.
To see Spark’s full report on ATGE stock, click here.
More about Adtalem Global Education
Covista, formerly known as Adtalem Global Education, is America’s largest healthcare educator, focused on healthcare workforce development across five accredited institutions. The company serves more than 97,000 students and has graduated 24,000 healthcare professionals in the past year, including 10% of U.S. nurses, twice as many MDs as any U.S. MD-granting school and the largest number of Doctors of Veterinary Medicine in the country.
Backed by scale, broad program offerings and national reach, Covista positions itself as essential infrastructure for the U.S. healthcare talent pipeline. Its model emphasizes strong academic outcomes, practice-ready clinicians and deep partnerships with healthcare systems, targeting acute workforce shortages, including in rural and underserved communities.
Effective February 24, 2026, the company’s stock began trading on the New York Stock Exchange under the ticker symbol CVSA, reinforcing its standalone identity as a healthcare education leader. Management highlights durable secular demand, strong cash generation and a robust balance sheet as supporting its strategy and investment capacity.
Average Trading Volume: 514,865
Technical Sentiment Signal: Hold
Current Market Cap: $3.37B
See more data about ATGE stock on TipRanks’ Stock Analysis page.
